Feeds:
Posts
Comments

Posts Tagged ‘management fee’

    Senator McConnell’s Dilemma:   To Serve Patients or Investors?

Screen Shot 2017-07-18 at 3.02.20 PM

When evaluating health care investments it is important to analyze the structure of leading drug and medical equipment companies.  A close look indeed reveals a derivative driven system in which private equity and hedge funds increase demand for drug payments by purchasing the rights to the cash flows from key drugs.  Patients are indeed unaware that many of the drugs they consume are now owned in part by private equity investors.

(more…)

Read Full Post »

In a front page story Sunday May 20, 2012, Ted Sickinger of the Oregonian provided a detailed review of private equity valuation concerns.  This portfolio of opaque investments has grown substantially and poses unique risks to Oregonian PERS participants.  In his article, Sickinger notes this analysis is based upon original Parish & Company research.

Although an excellent article, there was still no mention that Oregon PERS does not keep independent records of “carried interest” fees paid to the private equity general partners nor K-1 annual partnership statements summarizing activity.  These private equity firms include Blackstone, KKR and Fortress. The fees cited in the article are for “management” and do not include the carried interest fees which are typically 10 times the annual management fee.

It is indeed remarkable that the Oregon State Treasury does not maintain these independent records.

Here is a link to the story:  Oregon PERS: Private equity investments pose unclear future

Read Full Post »